Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 March 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 194 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 
 

 

Export 10 results:
Author Title Type [ Year(Asc)]
Filters: Author is de Abajo, F. J.  [Clear All Filters]
2016
C. Huerta, Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P. C., De Bruin, M. L., Slattery, J., de Groot, M. C., Hesse, U., Rottenkolber, M., Schmiedl, S., Montero, D., Bate, A., Ruigomez, A., Garcia-Rodriguez, L. A., Johansson, S., de Vries, F., Schlienger, R. G., Reynolds, R. F., Klungel, O. H., and de Abajo, F. J., “Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 56-65, 2016.
G. Requena, Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., Miret, M., Schneider, C., Souverein, P. C., Webb, D., Afonso, A., Boudiaf, N., Martin, E., Oliva, B., Alvarez, A., de Groot, M. C., Bate, A., Johansson, S., Schlienger, R., Reynolds, R., Klungel, O. H., and de Abajo, F. J., “Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 66-78, 2016.
2014
V. Abbing-Karahagopian, Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., Hasford, J., Dijk, L., de Abajo, F. J., Weil, J. G., Grimaldi-Bensouda, L., Egberts, A. C., Reynolds, R. F., and Klungel, O. H., “Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project”, Curr Clin Pharmacol, vol. 9, pp. 130-8, 2014.
2010
S. Johansson, Wallander, M. A., de Abajo, F. J., and Rodriguez, L. A. Garcia, “Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios”, Drug Saf, vol. 33, pp. 223-32, 2010.
2008
F. J. de Abajo and Garcia-Rodriguez, L. A., “Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents”, Arch Gen Psychiatry, vol. 65, pp. 795-803, 2008.
2004
F. J. de Abajo, Montero, D., Madurga, M., and Rodriguez, L. A. Garcia, “Acute and clinically relevant drug-induced liver injury: a population based case-control study”, Br J Clin Pharmacol, vol. 58, pp. 71-80, 2004.
2001
F. J. de Abajo and Rodriguez, L. A. Garcia, “Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations”, BMC Clin Pharmacol, vol. 1, p. 1, 2001.
2000
F. J. de Abajo, Jick, H., Derby, L., Jick, S., and Schmitz, S., “Intracranial haemorrhage and use of selective serotonin reuptake inhibitors”, Br J Clin Pharmacol, vol. 50, pp. 43-7, 2000.
1999
F. J. de Abajo, Rodriguez, L. A., and Montero, D., “Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study”, Bmj, vol. 319, pp. 1106-9, 1999.
F. J. de Abajo and Rodriguez, L. A., “Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs”, Br J Clin Pharmacol, vol. 47, pp. 307-13, 1999.
[Page last reviewed 10 March 2020]